Supply of Cryopreservation-Grade Dimethyl Sulfoxide (DMSO) Products
This is a large award for Medical Equipment & Pharmaceuticals — above three-quarters of comparable contracts. Based on 9,456 valued Medical Equipment & Pharmaceuticals tenders in our corpus.
NHS Blood and Transplant publishes Medical Equipment & Pharmaceuticals work continuously — 205 notices, roughly one every 3 days. This is a stream to watch, not a cycle to wait for.
58% of NHS Blood and Transplant’s awards go to a supplier it has used before.
Which is the argument for getting on the list rather than winning this one. The incumbent is rarely the last winner — it is the roster. See the retention odds by category →
NHS Blood and Transplant (NHSBT) is seeking to engage with suppliers and manufacturers of Dimethyl Sulphoxide (DMSO) used in the cryopreservation of stem cell and immunotherapy products.
The purpose of this preliminary market engagement is to improve NHSBT's understanding of the current market, available products, supply chain capabilities, packaging options, quality standards, innovation opportunities, and market capacity ahead of a potential future procurement exercise.
The requirement is expected to include sterile, pyrogen-free DMSO with a minimum purity of 99.9%, supplied in a range of formats including vials, bottles, bags and/or syringes suitable for use within NHSBT Cellular and Molecular Therapies laboratories.
NHSBT is also interested in understanding supplier capabilities relating to quality assurance, business continuity arrangements, supply resilience, sustainability initiatives, and future product developments.
What the notice asks for
The purpose of this preliminary market engagement
The purpose of this preliminary market engagement is to improve NHSBT's understanding of the current market, available products, supply chain capabilities, packaging options, quality standards, innovation opportunities, and market capacity ahead of a potential future procurement exercise.
The requirement is expected to include sterile
The requirement is expected to include sterile, pyrogen-free DMSO with a minimum purity of 99.9%, supplied in a range of formats including vials, bottles, bags and/or syringes suitable for use within NHSBT Cellular and Molecular Therapies laboratories.
NHSBT is also interested in understanding supplier
NHSBT is also interested in understanding supplier capabilities relating to quality assurance, business continuity arrangements, supply resilience, sustainability initiatives, and future product developments.
Sentences from the notice that state an obligation, surfaced automatically and shown in the order they appear. Not an exhaustive list — always confirm against the tender documents.
Make the case to bid
Reveal who to approach at NHS Blood and Transplant, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
The full intelligence dossier
Our agent reads NHS Blood and Transplant’s accounts, hunts live signals, finds the people who decide — and hands you a bid strategy plus a go-to-market influence plan, including what your team should post this week. You approve every paid step.
Five included while we’re in beta, and the agent asks before it spends on any paid step.
- OCID
- ocds-h6vhtk-06dfe3
- Stage
- planning · Planning
- Source
- Find a Tender
- Buyer ref
- 075629-2026
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
NHS Blood and Transplant’s tender network